Real Heart (HEART) - Total Liabilities

Latest as of June 2025: Skr13.59 Million SEK ≈ $1.46 Million USD

Based on the latest financial reports, Real Heart (HEART) has total liabilities worth Skr13.59 Million SEK (≈ $1.46 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Real Heart - Total Liabilities Trend (2010–2024)

This chart illustrates how Real Heart's total liabilities have evolved over time, based on quarterly financial data. See HEART net working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Real Heart Competitors by Total Liabilities

The table below lists competitors of Real Heart ranked by their total liabilities.

Company Country Total Liabilities
Park & Bellheimer AG
F:PKB
Germany €23.21 Million
Grand Pacific Petrochemical Corp Pref
TW:1312A
Taiwan NT$34.34 Billion
Property Perfect Public Company Limited
BK:PF
Thailand ฿32.61 Billion
Garovaglio y Zorraquin S.A.
BA:GARO
Argentina AR$41.64 Billion
Vizione Holdings Bhd
KLSE:7070
Malaysia RM294.01 Million
SeaStar Medical Holding Corporation
NASDAQ:ICU
USA $3.74 Million
Gaxos.ai Inc
NASDAQ:GXAI
USA $569.31K
Mustera Property Group Ltd
AU:MPX
Australia AU$24.55 Million

Liability Composition Analysis (2010–2024)

This chart breaks down Real Heart's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is Real Heart worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 2.96 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.18 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.15 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Real Heart's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Real Heart (2010–2024)

The table below shows the annual total liabilities of Real Heart from 2010 to 2024.

Year Total Liabilities Change
2024-12-31 Skr15.94 Million
≈ $1.72 Million
-22.62%
2023-12-31 Skr20.60 Million
≈ $2.22 Million
-7.08%
2022-12-31 Skr22.17 Million
≈ $2.39 Million
+239.78%
2021-12-31 Skr6.53 Million
≈ $702.20K
+2.75%
2020-12-31 Skr6.35 Million
≈ $683.39K
-16.57%
2019-12-31 Skr7.61 Million
≈ $819.12K
-6.31%
2018-12-31 Skr8.12 Million
≈ $874.25K
+26.15%
2017-12-31 Skr6.44 Million
≈ $693.01K
+60.72%
2016-12-31 Skr4.01 Million
≈ $431.18K
+534.12%
2015-12-31 Skr631.85K
≈ $68.00K
-26.28%
2014-12-31 Skr857.12K
≈ $92.24K
+1.78%
2013-12-31 Skr842.11K
≈ $90.62K
+91.93%
2012-12-31 Skr438.75K
≈ $47.22K
+613.58%
2011-12-31 Skr61.49K
≈ $6.62K
-15.36%
2010-12-31 Skr72.65K
≈ $7.82K
--

About Real Heart

ST:HEART Sweden Medical Devices
Market Cap
$12.48 Million
Skr115.97 Million SEK
Market Cap Rank
#26485 Global
#570 in Sweden
Share Price
Skr23.20
Change (1 day)
+1.75%
52-Week Range
Skr13.00 - Skr29.00
All Time High
Skr1625.78
About

Scandinavian Real Heart AB (Publ) engages in the design and development of an artificial heart. The company develops Realheart TAH to treat advanced stage heart failure. It also develops RealVAD for pulsating left ventricle assist; PulsePump, a pulsating flow for heart and lung machines; and Sternal Prosthesis to fix the sternum after open-chest surgery. The company was founded in 1999 and is bas… Read more